Cargando…

Impfungen gegen COVID-19 – was haben wir gelernt?

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638500/
https://www.ncbi.nlm.nih.gov/pubmed/36373141
http://dx.doi.org/10.1007/s12688-022-00571-x
_version_ 1784825428330938368
collection PubMed
description
format Online
Article
Text
id pubmed-9638500
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-96385002022-11-07 Impfungen gegen COVID-19 – was haben wir gelernt? Rheuma Plus Aktuell Springer Vienna 2022-11-04 2022 /pmc/articles/PMC9638500/ /pubmed/36373141 http://dx.doi.org/10.1007/s12688-022-00571-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Aktuell
Impfungen gegen COVID-19 – was haben wir gelernt?
title Impfungen gegen COVID-19 – was haben wir gelernt?
title_full Impfungen gegen COVID-19 – was haben wir gelernt?
title_fullStr Impfungen gegen COVID-19 – was haben wir gelernt?
title_full_unstemmed Impfungen gegen COVID-19 – was haben wir gelernt?
title_short Impfungen gegen COVID-19 – was haben wir gelernt?
title_sort impfungen gegen covid-19 – was haben wir gelernt?
topic Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638500/
https://www.ncbi.nlm.nih.gov/pubmed/36373141
http://dx.doi.org/10.1007/s12688-022-00571-x